Clinical Trials Logo

Clinical Trial Summary

The purpose of this 2-group, randomized, controlled trial is to evaluate the refined SystemCHANGE™ against attention control patient education in CKD patients taking RAAS medications.


Clinical Trial Description

In this study, the investigators will test a refined SystemCHANGE™ in patients taking RAAS inhibiting medications. Participants will be recruited from two sources: 1) the largest and most comprehensive health care system in the state and 2) one of the largest essential health care systems in the country. Data are collected at baseline, 8 weeks (immediately post-intervention), and 12 weeks. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04616612
Study type Interventional
Source Indiana University
Contact
Status Completed
Phase N/A
Start date December 15, 2021
Completion date February 6, 2024

See also
  Status Clinical Trial Phase
Completed NCT04579315 - Long-term Effects of the New Nordic Renal Diet in Patients With Moderate Chronic Kidney Disease N/A
Recruiting NCT05732727 - Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease Phase 3
Active, not recruiting NCT02165878 - KoreaN Cohort Study for Outcome in Pediatric Patients With Chronic Kidney Disease
Completed NCT01227616 - Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on Hemodialysis Phase 4
Not yet recruiting NCT06344936 - Drug-drug Interaction Study of HRS-1780 Tablets in Healthy Subjects Phase 1